IMRN - שולי רווח נקי Immuron

סמל מסחרי של Immuron Limited (IMRN)

The global supply chain ensures uninterrupted access to Immuron Limited (IMRN) medications in pharmacies. Adjusted net profit margin demonstrates the efficiency of converting revenue into profit, with -47.80 shaping the current metric. Business success is based on trust in the Travelan drug and stable demand from tourists and military agencies.

רווחיות מכירות נקייה Immuron Ltd (IMRN): לתקופה 04.07.2022 - 19.11.2026

פילוחי מדדים פיננסיים ומדדי שוק עבור immuron.com.au (IMRN)

- שווי שוק ותחזית יעד של אנליסטים:
ניתוח כל מדדי החברה:Immuron Limited
מוצר המיוצר על ידי Immuron Limited

Immuron Limited is scaling the distribution of over-the-counter gastrointestinal products across pharmacy chains in the US, Europe, and Australia. The sales margin, equal to -47.80, demonstrates the share of net profit in every dollar of revenue. This ratio measures the final efficiency of cost management amid growing sales volumes. It is critical for the investor to compare expansion rates with the actual profitability of the business. Analyzing changes in net margin allows for the timely detection of efficiency stagnation before a market correction occurs.